Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?

Trends in Pharmacological Sciences

Volumn 30, Issue 9, 2009, Pages 475-483

  Cicchetti, Francesca ^a,b   Drouin Ouellet, Janelle ^a   Gross, Robert E ^c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MANEB; PARAQUAT; ROTENONE;

DISEASE MODEL; DISEASE PREDISPOSITION; ECOTOXICOLOGY; EXPERIMENTAL ANIMAL; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TOXICITY TESTING;

ANIMALS; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; HUMANS; MANEB; PARAQUAT; PARKINSON DISEASE, SECONDARY; PESTICIDES; ROTENONE;

EID: 69549084529     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2009.06.005     Document Type: Review

References (66)

1. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
2. Lim S.Y., et al. Overview of the extranigral aspects of Parkinson disease. Arch Neurol 66 (2009) 167-172
3. Hatcher J.M., et al. Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol Sci 29 (2008) 322-329
4. Ascherio A., et al. Pesticide exposure and risk for Parkinson's disease. Ann Neurol 60 (2006) 197-203
5. Ferraz H.B., et al. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 38 (1988) 550-553
6. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10 (2000) 524-530
7. Uversky V.N. Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res 318 (2004) 225-241
8. Wang X.F., et al. Inhibitory effects of pesticides on proteasome activity: implication in Parkinson's disease. Neurobiol Dis 23 (2006) 198-205
9. Olanow C.W. The pathogenesis of cell death in Parkinson's disease. Mov Disord 22 Suppl 17 (2007) S335-342
10. Shimizu K., et al. Carrier-mediated processes in blood--brain barrier penetration and neural uptake of paraquat. Brain Res 906 (2001) 135-142
11. Miller G.W. Paraquat: the red herring of Parkinson's disease research. Toxicol Sci 100 (2007) 1-2
12. Fei Q., et al. Paraquat neurotoxicity is mediated by a Bak-dependent mechanism. J Biol Chem 283 (2008) 3357-3364
13. Zhang J., et al. Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J Neurochem 84 (2003) 336-346
14. Fei Q., and Ethell D.W. Maneb potentiates paraquat neurotoxicity by inducing key Bcl-2 family members. J Neurochem 105 (2008) 2091-2097
15. Betarbet R., et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3 (2000) 1301-1306
16. Cannon J.R., et al. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 34 (2009) 279-290
17. Inden M., et al. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. J Neurochem 101 (2007) 1491-1504
18. Rojo A.I., et al. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats. Exp Neurol 208 (2007) 120-126
19. Fleming S.M., et al. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol 187 (2004) 418-429
20. Höglinger G.U., et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 84 (2003) 491-502
21. Höglinger G.U., et al. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem 95 (2005) 930-939
22. Lapointe N., et al. Rotenone induces non-specific central nervous system and systemic toxicity. Faseb J 18 (2004) 717-719
23. Luo C., et al. Alpha-synuclein and tyrosine hydroxylase expression in acute rotenone toxicity. Int J Mol Med 19 (2007) 517-521
24. Pasha M.K., et al. Increased myocardial N-myristoyltransferase activity in rotenone model of Parkinsonism. Int J Mol Med 15 (2005) 987-991
25. Richter F., et al. Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice. J Neurosci Res 85 (2007) 681-691
26. Yang Y., et al. Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. Int J Neuropsychopharmacol 9 (2006) 51-61
27. Zhu C., et al. Variable effects of chronic subcutaneous administration of rotenone on striatal histology. J Comp Neurol 478 (2004) 418-426
28. Höglinger G.U., et al. The rotenone model of parkinsonism - the five years inspection. J Neural Transm Suppl (2006) 269-272
29. Lerner A., and Bagic A. Olfactory pathogenesis of idiopathic Parkinson disease revisited. Mov Disord 23 (2008) 1076-1084
30. Ling Z., et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 17 (2002) 116-124
31. Thiruchelvam M., et al. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?. Brain Res 873 (2000) 225-234
32. Thiruchelvam M., et al. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J Neurosci 20 (2000) 9207-9214
33. Li X., et al. Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice. Pharmacol Biochem Behav 82 (2005) 345-352
34. Thiruchelvam M., et al. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23 (2002) 621-633
35. Barlow B.K., et al. Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates. J Neurochem 85 (2003) 1075-1086
36. McCormack A.L., et al. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10 (2002) 119-127
37. Thiruchelvam M., et al. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur J Neurosci 18 (2003) 589-600
38. Corasaniti M.T., et al. Evidence that paraquat is able to cross the blood-brain barrier to a different extent in rats of various age. Funct Neurol 6 (1991) 385-391
39. Cicchetti F., et al. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Neurobiol Dis 20 (2005) 360-371
40. Saint-Pierre M., et al. Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats. J Neurochem 98 (2006) 760-772
41. Satomi Y., et al. Gene expression analysis of the lung following paraquat administration in rats using DNA microarray. J Toxicol Sci 29 (2004) 91-100
42. Drouin-Ouellet J., et al. Short-term effects of paraquat and maneb treatment in mice: evidence of brain and lung injuries. J Environ Neurosci Biomed 1 (2007) 78-90
43. De Gori N., et al. Behavioural and electrocortical changes induced by paraquat after injection in specific areas of the brain of the rat. Neuropharmacology 27 (1988) 201-207
44. Alam M., et al. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA. Behav Brain Res 151 (2004) 117-124
45. Antkiewicz-Michaluk L., et al. Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone. Int J Neuropsychopharmacol 7 (2004) 155-163
46. Saravanan K.S., et al. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease. Brain Res 1049 (2005) 147-155
47. Sindhu K.M., et al. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion. Brain Res 1051 (2005) 25-34
48. Sindhu K.M., et al. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine. Pharmacol Biochem Behav 84 (2006) 321-329
49. Saravanan K.S., et al. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats. Neurochem Int 49 (2006) 28-40
50. Garcia-Garcia F., et al. Sleep disturbances in the rotenone animal model of Parkinson disease. Brain Res 1042 (2005) 160-168
51. 2 upon chronic rotenone treatment. Free Radic Biol Med 39 (2005) 133-142
52. Sherer T.B., et al. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 179 (2003) 9-16
53. Ling Z., et al. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp Neurol 190 (2004) 373-383
54. Yang Y., et al. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats. J Neurosci Res 80 (2005) 442-449
55. Huang J., et al. A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease. Biomaterials 27 (2006) 937-946
56. Betarbet R., et al. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin- proteasome system. Neurobiol Dis 22 (2006) 404-420
57. Phinney A.L., et al. Enhanced sensitivity of dopaminergic neurons to rotenone- induced toxicity with aging. Parkinsonism Relat Disord 12 (2006) 228-238
58. He Y., et al. Role of nitric oxide in rotenone-induced nigro-striatal injury. J Neurochem 86 (2003) 1338-1345
59. Manning-Bog A.B., et al. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 277 (2002) 1641-1644
60. Peng J., et al. The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J Biol Chem 279 (2004) 32626-32632
61. Ossowska K., et al. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?. Eur J Neurosci 22 (2005) 1294-1304
62. Ossowska K., et al. Influence of paraquat on dopaminergic transporter in the rat brain. Pharmacol Rep 57 (2005) 330-335
63. Li X., et al. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice. Chin Med J (Engl) 118 (2005) 1357-1361
64. Shepherd K.R., et al. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice. Pharmacol Biochem Behav 83 (2006) 349-359
65. Shimizu K., et al. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res 976 (2003) 243-252
66. Kuter K., et al. Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Res 1155 (2007) 196-207